Centers for Disease Control and Prevention (CDC) Reports Asthma As Most Common Underlying Condition In Severe Cases of H1N1 Swine Flu; Cannabis Science Reports That Cannabis Has Been Long Used To Treat Asthma And Cannabis May Also Help Reduce Deaths From Adult Respiratory Distress Syndrome From Swine And Avian Flu
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, notes a report by epidemiologists at the Centers for Disease Control and Prevention (CDC) saying that, among people hospitalized with severe cases of the pandemic strain of H1N1 Swine Flu, asthma is by far the most common underlying condition associated with the disease. In fact, among the hospitalized adults, 26 percent had asthma.
Cannabis Science, Inc. President & CEO Dr. Robert Melamede stated, “There is a long history of cannabis being used in the treatment of asthma, and that is an area where we are currently working on product development. Obviously, it fits well with our development of phytocannabinoid pharmaceutical products to help reduce ARDS-associated deaths from both the H1N5 Avian and H1N1 Swine Influenza infections. As a reminder, we urged all cannabis consumers in the past that if you come down with the flu, cease smoking and switch to edibles. We believe that smoking marijuana when a person has influenza will lead to some unnecessary deaths, whereas eating it can prevent unnecessary deaths.”